Literature DB >> 1331083

Phosphorylation of Asn-linked oligosaccharides located at novel sites on the lysosomal enzyme cathepsin D.

A B Cantor1, S Kornfeld.   

Abstract

We have examined the phosphorylation of Asn-linked oligosaccharides introduced at seven novel sites on human cathepsin D to determine whether the location of an oligosaccharide on a lysosomal enzyme affects its ability to serve as a substrate for UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (phosphotransferase), the enzyme that catalyzes the initial step in the biosynthesis of mannose 6-phosphate residues. The glycosylation sites were introduced into the cathepsin D cDNA by site-directed mutagenesis and were selected to be widely distributed over the surface of the molecule. When the constructs were expressed in Xenopus oocytes, the oligosaccharides at each glycosylation site were phosphorylated at levels considerably above background (19-70% phosphorylation versus < 0.4% for the secretory protein glycopepsinogen). However, oligosaccharides located closer to the essential components of the phosphotransferase recognition domain (lysine 203 and amino acids 265-292) were phosphorylated better than oligosaccharides located further away. Similar results were obtained for oligosaccharides at homologous sites on a pepsinogen/cathepsin D chimera containing only lysine 203 and residues 265-319 of cathepsin D, although the absolute levels of phosphorylation were lower. These results demonstrate that there is considerable flexibility in the placement of glycosylation sites on cathepsin D in terms of the ability of the oligosaccharides to serve as substrates for phosphotransferase, although oligosaccharides located closer to the phosphotransferase recognition determinant are preferentially phosphorylated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331083

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Multiple Domains of GlcNAc-1-phosphotransferase Mediate Recognition of Lysosomal Enzymes.

Authors:  Eline van Meel; Wang-Sik Lee; Lin Liu; Yi Qian; Balraj Doray; Stuart Kornfeld
Journal:  J Biol Chem       Date:  2016-02-01       Impact factor: 5.157

2.  Effect of carbohydrate position on lysosomal transport of procathepsin L.

Authors:  R G Lingeman; D S Joy; M A Sherman; S E Kane
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

3.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

4.  Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms.

Authors:  C R Brunetti; K S Dingwell; C Wale; F L Graham; D C Johnson
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Functions of the alpha, beta, and gamma subunits of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase.

Authors:  Yi Qian; Intaek Lee; Wang-Sik Lee; Meiqian Qian; Mariko Kudo; William M Canfield; Peter Lobel; Stuart Kornfeld
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

6.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Several cooperating binding sites mediate the interaction of a lysosomal enzyme with phosphotransferase.

Authors:  R Tikkanen; M Peltola; C Oinonen; J Rouvinen; L Peltonen
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

8.  Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts.

Authors:  J N Glickman; S Kornfeld
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.